Showing 3831-3840 of 7016 results for "".
How Do We Manage Medications in Elderly Populations?
https://reachmd.com/programs/advances-in-long-term-care-medicine/how-do-we-manage-medications-in-elderly-populations/4052/What risks does polypharmacy pose for elderly patients, and how should physicians manage medications in the population of their patients over age 65? Dr. Matthew Wayne, assistant professor of medicine at University Hospitals Case Medical Center in Cleveland, discusses the typical symptoms that mightHair Concerns in the Post Menopausal Patient
https://reachmd.com/programs/clinicians-roundtable/hair-concerns-in-the-post-menopausal-patient/7217/Host Dr. Prathima Setty is joined by Dr. Bethanee J Schlosser, Assistant Professor in Dermatology and Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine, Chicago, IL. Dr. Schlosser discusses hair concerns and changes in post menopausal patients. She also addresses the iMultidrug-Resistant Tuberculosis: Tackling a New Face of an Old Foe
https://reachmd.com/programs/grand-rounds-nation/multidrug-resistant-tuberculosis-tackling-a-new-face-of-an-old-foe/6947/Tuberculosis is an ancient disease that remains an important global cause of morbidity and mortality. In most cases, TB can be treated and cured by taking a combination of several drugs for 6 to 12 months. When inappropriate or incomplete treatment takes place, however, TB bacteria can develop multHypoactive Sexual Desire Disorder: The Impact on the Midlife Woman
https://reachmd.com/programs/clinicians-roundtable/hypoactive-sexual-desire-disorder-the-impact-on-the-midlife-woman/7220/Hypoactive sexual desire disorder (HSDD) is the most prevalent sexual disorder for women of all ages, but it is also one of the most difficult to address. Clinicians need to understand the implications and address the concerns of their patients. Host Dr. Prathima Setty discusses this topic with SherHow Pharmacists Can Improve Our Nation’s Health
https://reachmd.com/programs/grand-rounds-nation/how-pharmacists-can-improve-our-nations-health/7247/The expanded role of 21st century pharmacists will position them to have greater impact in the shifting landscape of health care and public health. Beyond the dispensing of medications, pharmacists also provide a spectrum of prevention services to help improve health outcomes. In the United States,Encouraging Physician Involvement in Health Care Reform
https://reachmd.com/programs/second-opinion-live/encouraging-physician-involvement-in-health-care-reform/4737/It seems every day there is a new batch of developments in the political tussle over health care reform. Many members of the medical community are frustrated at the tenor of the debate in Washington, and concerned that the issues sacred to physicians and other medical professionals appear to have taCDC - Prescription Drug Overdoses: An American Epidemic, Part 1
https://reachmd.com/programs/grand-rounds-nation/cdc-prescription-drug-overdoses-an-american-epidemic-part-1/6319/The United States is in the grip of an epidemic of prescription drug overdoses. Over 27,000 people died from overdoses in 2007, a number that has risen five-fold since 1990 and has never been higher. Prescription drugs are now involved in more overdose deaths than heroin and cocaine combined. For heUnusual Transplant-associated Infections: Just How Unusual?
https://reachmd.com/programs/grand-rounds-nation/unusual-transplant-associated-infections-just-how-unusual/7248/Transplant centers have very little time to evaluate if the need for transplant for a particular recipient outweighs the possible risk of infection from a potential donor. In the case of transplants from deceased donors, time and other factors limit the testing that can be performed prior to transplUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2
https://reachmd.com/programs/grand-rounds-nation/university-of-arizona-preclinical-stage-alzheimers-disease-characterizing-and-defining-the-transition-between-normal-and-pathological-cognitive-aging-part-2/6407/For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later inUniversity of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1
https://reachmd.com/programs/grand-rounds-nation/university-of-arizona-preclinical-stage-alzheimers-disease-characterizing-and-defining-the-transition-between-normal-and-pathological-cognitive-aging-part-1/6406/For people who carry genetic predispositions toward Alzheimer's disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in